-
1 Comment
Nova Eye Medical Limited is currently in a long term downtrend where the price is trading 4.9% below its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Nova Eye Medical Limited's total revenue sank by 8.5% to $7M since the same quarter in the previous year.
Its net income has increased by 40.1% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 577.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Nova Eye Medical Limited gets an overall score of 2/5.
CurrencyCode | AUD |
---|---|
Exchange | AU |
Sector | Healthcare |
Industry | Medical Devices |
ISIN | AU0000094252 |
Market Cap | 31M |
---|---|
Target Price | 0.415 |
Beta | 0.68 |
PE Ratio | None |
Dividend Yield | None |
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EYE.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025